Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 5, 2015, Pages 557-565

  Paulin, Laura M ^a   Diette, Gregory B ^a,b   Blanc, Paul D ^c   Putcha, Nirupama ^a   Eisner, Mark D ^e   Kanner, Richard E ^f   Belli, Andrew J ^a   Christenson, Stephanie ^d   Tashkin, Donald P ^g   Han, MeiLan ^h   Graham Barr, R ⁱ   Hansel, Nadia N ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GENENTECH INC   (United States)

^f UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ NONE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Job exposure matrix; Occupational exposure; Quality of life; Work related

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; SENSITIVITY AND SPECIFICITY; SHORT FORM 12; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; DISEASE COURSE; EPIDEMIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AGED; DISEASE PROGRESSION; EFFECT MODIFIER, EPIDEMIOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SMOKING;

EID: 84923917295     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201408-1407OC     Document Type: Article

References (35)

1. Global status report on noncommunicable diseases. Geneva, Switzerland: World Health Organization; 2010.
2. Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, Katz PP, Blanc PD. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003;22:462-469.
3. Becklake MR. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;140:S85-S91.
4. Hnizdo E, Vallyathan V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup Environ Med 2003;60:237-243.
5. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182:693-718.
6. Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G; Environmental and Occupational Health Assembly, American Thoracic Society. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003;167:787-797.
7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. 2013 [accessed 2014 Jun 1]. Available from: http://www.goldcopd.org/
8. Makris D, Moschandreas J, Damianaki A, Ntaoukakis E, Siafakas NM, Milic Emili J, Tzanakis N. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med 2007; 101:1305-1312.
9. Garcia-Aymerich J, Monsó E, Marrades RM, Escarrabill J, Fé lez MA, Sunyer J, Antó JM; EFRAM Investigators. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 2001;164:1002-1007.
10. Blanc PD, Eisner MD, Trupin L, Yelin EH, Katz PP, Balmes JR. The association between occupational factors and adverse health outcomes in chronic obstructive pulmonary disease. Occup Environ Med 2004;61:661-667.
11. Harber P, Tashkin DP, Simmons M, Crawford L, Hnizdo E, Connett J; Lung Health Study Group. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:994-1000.
12. Rodríguez E, Ferrer J, Martí S, Zock JP, Plana E, Morell F. Impact of occupational exposure on severity of COPD. Chest 2008;134:1237-1243.
13. Caillaud D, Lemoigne F, Carré P, Escamilla R, Chanez P, Burgel PR, Court-Fortune I, Jebrak G, Pinet C, Perez T, et al.; Initiative BPCO Scientific Committee. Association between occupational exposure and the clinical characteristics of COPD. BMC Public Health 2012;12:302.
14. Rodríguez E, Ferrer J, Zock JP, Serra I, Antó JM, de Batlle J, Kromhout H, Vermeulen R, Donaire-González D, Benet M, et al.; PAC-COPD Study Group. Lifetime occupational exposure to dusts, gases and fumes is associated with bronchitis symptoms and higher diffusion capacity in COPD patients. PLoS ONE 2014;9:e88426.
15. Doney B, Hnizdo E, Graziani M, Kullman G, Burchfiel C, Baron S, Fujishiro K, Enright P, Hankinson JL, Stukovsky KH, et al. Occupational risk factors for COPD phenotypes in the Multi-Ethnic Study of Atherosclerosis (MESA) lung study. COPD 2014;11:368-380.
16. Paulin LM, Belli AJ, Diette GB, Eisner MD, Kanner R, Barr RG, Hansel N. Occupational exposures are associated with worse morbidity in a nation-wide sample of patients with COPD [abstract]. Am J Respir Crit Care Med 2013;187:A2075.
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
18. Couper D, LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, et al.; SPIROMICS Research Group. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax 2014;69:491-494.
19. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
20. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 2000;22:1121-1145.
21. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-654.
22. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-586.
23. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
24. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med 2002;166:111-117.
25. Blanc PD, Eisner MD, Balmes JR, Trupin L, Yelin EH, Katz PP. Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. Am J Ind Med 2005;48:110-117.
26. Putcha N, Puhan MA, Drummond MB, Han MK, Regan EA, Hanania NA, Martinez CH, Foreman M, Bhatt SP, Make B, et al. A simplified score to quantify comorbidity in COPD. PLoS One 2014;9:e114438.
27. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2:75-79.
28. Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med 2014;2:195-203.
29. Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013;187:382-386.
30. Quinlan PJ, Earnest G, Eisner MD, Yelin EH, Katz PP, Balmes JR, Blanc PD. Performance of self-reported occupational exposure compared to a job-exposure matrix approach in asthma and chronic rhinitis. Occup Environ Med 2009;66:154-160.
31. Becklake MR, Lalloo U. The 'healthy smoker': a phenomenon of health selection? Respiration 1990;57:137-144.
32. Clougherty JE. A growing role for gender analysis in air pollution epidemiology. Environ Health Perspect 2010;118:167-176.
33. Silvaggio T, Mattison DR. Setting occupational health standards: toxicokinetic differences among and between men and women. J Occup Med 1994;36:849-854.
34. Eng A, 't Mannetje A, McLean D, Ellison-Loschmann L, Cheng S, Pearce N. Gender differences in occupational exposure patterns. J Occup Environ Med 2011;68:888-894.
35. Blanc PD, Eisner MD, Earnest G, Trupin L, Balmes JR, Yelin EH, Gregorich SE, Katz PP. Further exploration of the links between occupational exposure and chronic obstructive pulmonary disease. J Occup Environ Med 2009;51:804-810.